| Age in years |
32 (26-38) |
32 (27-39) |
32 (27-38) |
31 (26-38) |
|
|
|
|
|
| 15-24 |
35,446 (16.9%) |
7,379 (13.9%) |
8,194 (16.4%) |
19,873 (18.6%) |
| 25-34 |
95,885 (45.7%) |
23,767 (44.8%) |
23,193 (46.5%) |
48,925 (45.7%) |
| 35-44 |
53,695 (25.6%) |
14,714 (27.7%) |
12,574 (25.2%) |
26,407 (24.7%) |
| 45-54 |
18,641 (8.9%) |
5,434 (10.2%) |
4,455 (8.9%) |
8,752 (8.2%) |
| 55+ |
6,317 (3.0%) |
1,750 (3.3%) |
1,432 (2.9%) |
3,135 (2.9%) |
| Gender |
|
|
|
|
| Male |
68,485 (32.6%) |
17,251 (32.5%) |
15,848 (31.8%) |
35,386 (33.0%) |
| Female |
141,499 (67.4%) |
35,793 (67.5%) |
34,000 (68.2%) |
71,706 (67.0%) |
| Known to be pregnant (females only) |
30,369 (21.5%) |
7,643 (21.4%) |
8,924 (26.2%) |
13,802 (19.2%) |
| District |
|
|
|
|
| Rural |
7,772 (3.7%) |
2,685 (5.1%) |
1,862 (3.7%) |
3,225 (3.0%) |
| Urban |
202,212 (96.3%) |
50,359 (94.9%) |
47,986 (96.3%) |
103,867 (97.0%) |
| CD4 count at ART initiation (cells/µl) |
299 (172-453) |
227 (130-313) |
306 (176-425) |
368 (211-557) |
| Median days since recent CD4 count |
0 (0-5) |
0 (0-9) |
0 (0-11) |
0 (0-0) |
| missing_init_cd4 |
22,440 (10.7%) |
1,815 (3.4%) |
2,918 (5.9%) |
17,707 (16.5%) |
| <200 (of paritcipants with CD4 test done) |
56,369 (30.1%) |
21,839 (42.6%) |
13,700 (29.2%) |
20,830 (23.3%) |
| TB screening status at initiation |
|
|
|
|
| TB |
21,455 (10.2%) |
8,015 (15.1%) |
5,465 (11.0%) |
7,975 (7.4%) |
| No TB |
118,598 (56.5%) |
31,066 (58.6%) |
30,927 (62.0%) |
56,605 (52.9%) |
| Not ascertained |
69,931 (33.3%) |
13,963 (26.3%) |
13,456 (27.0%) |
42,512 (39.7%) |
| TB screening status at initiation (participants with initiation CD4 count <200 cells/µl) |
|
|
|
|
| TB |
11,252 (20.0%) |
4,538 (20.8%) |
2,875 (21.0%) |
3,839 (18.4%) |
| No TB |
29,760 (52.8%) |
12,235 (56.0%) |
7,672 (56.0%) |
9,853 (47.3%) |
| Not ascertained |
15,357 (27.2%) |
5,066 (23.2%) |
3,153 (23.0%) |
7,138 (34.3%) |